Supplementary Data from Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

2025 0 citations

Abstract

<p>Supplementary Data containing the statistical analysis plan, Supplemental Figures 1-6 and Supplemental Tables 1 and 2</p>

Related Publications

Exercise Intensity and Longevity in Men

<h3>To the Editor.</h3> —The article by Dr Lee and colleagues<sup>1</sup>on intensity of physical activity and longevity provides additional evidence that physical activity is a...

1995 JAMA 229 citations

Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Purpose Treatment of advanced non–small-cell lung cancer with immune checkpoint inhibitors (ICIs) is characterized by durable responses and improved survival in a subset of pati...

2018 Journal of Clinical Oncology 1371 citations

Publication Info

Year
2025
Type
article
Citations
0
Access
Closed

External Links

Citation Metrics

0
OpenAlex

Cite This

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. (2025). Supplementary Data from Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders. . https://doi.org/10.1158/2159-8290.30834154

Identifiers

DOI
10.1158/2159-8290.30834154